| Product NDC: | 0187-0651 |
| Proprietary Name: | 8-MOP |
| Non Proprietary Name: | Methoxsalen |
| Active Ingredient(s): | 10 mg/1 & nbsp; Methoxsalen |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, GELATIN COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0187-0651 |
| Labeler Name: | Valeant Pharmaceuticals International |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA009048 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19541203 |
| Package NDC: | 0187-0651-42 |
| Package Description: | 50 CAPSULE, GELATIN COATED in 1 BOTTLE, GLASS (0187-0651-42) |
| NDC Code | 0187-0651-42 |
| Proprietary Name | 8-MOP |
| Package Description | 50 CAPSULE, GELATIN COATED in 1 BOTTLE, GLASS (0187-0651-42) |
| Product NDC | 0187-0651 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methoxsalen |
| Dosage Form Name | CAPSULE, GELATIN COATED |
| Route Name | ORAL |
| Start Marketing Date | 19541203 |
| Marketing Category Name | NDA |
| Labeler Name | Valeant Pharmaceuticals International |
| Substance Name | METHOXSALEN |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Photoabsorption [MoA],Photoactivated Radical Generator [EPC],Photosensitizing Activity [PE],Psoralen [EPC],Psoralens [Chemical/Ingredient] |